Fenretinide as an anti-angiogenic agent in neuroblastoma

被引：14

作者：

Ribatti, D

Raffaghello, L

Marimpietri, D

Cosimo, E

Montaldo, PG

Nico, B

Vacca, A

Ponzoni, M

机构：

[1] Univ Bari, Sch Med, Policlin, Dept Human Anat & Histol, I-70124 Bari, Italy

[2] G Gaslini Childrens Hosp, Lab Oncol, I-16148 Genoa, Italy

[3] Univ Bari, Sch Med, Policlin, Dept Biomed Sci & Human Oncol, I-70124 Bari, Italy

来源：

CANCER LETTERS | 2003年 / 197卷 / 1-2期

关键词：

anti-angiogenesis; fenretinide; neuroblastoma; angiogenesis; progression; endothelial cells; vascular network; TNP-470; HPR; therapy;

D O I：

10.1016/S0304-3835(03)00105-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Angiogenesis is a critical event in the progression of human neuroblastoma. This mini-review summarizes our literature and experimental data concerning the use of anti-angiogenic molecules, such as TNP-470 and fenretinide, in neuroblastoma treatment. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.

引用

页码：181 / 184

页数：4

共 16 条

[1] Angiogenesis in neuroblastoma:: Relationship to survival and other prognostic factors in a cohort of neuroblastoma patients [J].